Kimberly Smith
Family Medicine · Quincy, FLNPI 1588720973
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 252 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,511 and has fallen 99.0% since, to $15 in 2025.
Across 252 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$803
- Pfizer$481
- Lilly USA, LLC$457
- Sanofi-aventis U.S. LLC$407
- Boehringer Ingelheim$379
- Merck$316
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,261100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 46 | $803 |
| Pfizer | 34 | $481 |
| Lilly USA, LLC | 33 | $457 |
| Sanofi-aventis U.S. LLC | 24 | $407 |
| Boehringer Ingelheim | 18 | $379 |
| Merck | 22 | $316 |
| AstraZeneca | 15 | $256 |
| Gilead | 3 | $229 |
| Astellas Pharma US Inc | 7 | $128 |
| Amarin Pharma, Inc. | 6 | $98 |
| Amgen | 6 | $93 |
| GSK | 6 | $89 |
| Johnson & Johnson | 5 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| Bayer | 3 | $49 |
| Novartis | 3 | $47 |
| Sanofi Pasteur Inc. | 3 | $44 |
| AbbVie(2 entities) | 2 | $26 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Organon | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $14 |
| Global Blood Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,261 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 11 | $2,256 |
| Gabapentin | 18 | $392 |
| Lisinopril | 45 | $345 |
| Levothyroxine Sodium | 32 | $333 |
| Atorvastatin Calcium | 35 | $326 |
| Omeprazole | 18 | $311 |
| Metformin Hcl ErMetformin Hcl | 17 | $270 |
| Amlodipine Besylate | 30 | $235 |
| Metoprolol Succinate | 14 | $170 |
| Carvedilol | 27 | $160 |
| Metformin Hcl | 21 | $142 |
| Triamcinolone Acetonide | 12 | $114 |
| Tizanidine Hcl | 20 | $92 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $83 |
| Furosemide | 20 | $76 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Quincy
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.